Literature DB >> 19502655

Adipokines in a group of Mexican patients with nonalcoholic steatohepatitis.

Linda E Muñoz1, Paula Cordero, Liliana Torres, Alma Y Sauceda, Juan P Flores, Jose J Segura.   

Abstract

INTRODUCTION: Leptin has been implicated in the pathogenesis of nonalcoholic steatohepatitis. It has also been suggested that adiponectin plays an important role in the transition from fatty liver disease to nonalcoholic steatohepatitis.
OBJECTIVE: To evaluate whether leptin and adiponectin levels are related to the degree of necroinflammatory activity and fibrosis in patients with nonalcoholic steatohepatitis.
METHODS: Leptin and adiponectin levels were determined in 52 patients with nonalcoholic steatohepatitis and in 49 controls by enzyme-linked immunosorbent analysis.
RESULTS: Median (interquartile range) leptin levels were higher in patients with nonalcoholic steatohepatitis than in the controls (5.75 (12.3) ng mL-1 and 2.80 (2.40) ng mL-1, respectively; P = 0.0035). Adiponectin levels were lower in patients with nonalcoholic steatohepatitis than in the controls (6.55 (5.05) mg mL-1 and 9.30 (6.70) mg mL-1, respectively; P = 0.0218). Leptin levels were lower in overweight patients than in obese patients (2.25 (6.73) and 8.0 (16.0) ng mL-1, respectively; P = 0.0025). The amount of necroinflammatory activity observed in liver biopsies correlated positively with the amount of fibrosis (P < 0.0001). Increased lactate dehydrogenase correlated with increased fibrosis in patients with nonalcoholic steatohepatitis (P = 0.0012). Necroinflammatory activity correlated with adiponectin, g-glutamyltranspeptidase, the quantitative insulin-sensitivity check index, and ferritin (P < 0.05). Risk factors for nonalcoholic steatohepatitis in the logistic regression analysis were leptin, aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, and g-glutamyltranspeptidase (P < 0.0001). Only lactate dehydrogenase (P = 0.0012) was significantly associated with advanced fibrosis on logistic regression analysis.
CONCLUSIONS: Lactate dehydrogenase was associated with fibrosis and advanced fibrosis. Leptin was associated with nonalcoholic steatohepatitis but not with fibrosis or necroinflammatory activity. Adiponectin was related to necroinflammatory activity. Risk factors for nonalcoholic steatohepatitis were leptin and liver enzymes (aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, and gama-glutamyltranspeptidase).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19502655

Source DB:  PubMed          Journal:  Ann Hepatol        ISSN: 1665-2681            Impact factor:   2.400


  7 in total

1.  Nonalcoholic fatty liver disease across ethno-racial groups: do Asian-American adults represent a new at-risk population?

Authors:  James H Tabibian; Mariana Lazo; Francisco A Durazo; Hsin-Chieh Yeh; Myron J Tong; Jeanne M Clark
Journal:  J Gastroenterol Hepatol       Date:  2011-03       Impact factor: 4.029

2.  Hepatic glucose uptake is increased in association with elevated serum γ-glutamyl transpeptidase and triglyceride.

Authors:  Sun-pyo Hong; Tae Soo Noh; Seung-Hwan Moon; Young Seok Cho; Eun Jeong Lee; Joon Young Choi; Byung-Tae Kim; Kyung-Han Lee
Journal:  Dig Dis Sci       Date:  2013-12-11       Impact factor: 3.199

3.  Leptin induces an inflammatory phenotype in lean Wistar rats.

Authors:  Monique Allman; Mathew Wallace; Latausha Gaskin; Chantal A Rivera
Journal:  Mediators Inflamm       Date:  2010-01-26       Impact factor: 4.711

Review 4.  Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis.

Authors:  Stergios A Polyzos; Konstantinos N Aronis; Jannis Kountouras; Dimitrios D Raptis; Maria F Vasiloglou; Christos S Mantzoros
Journal:  Diabetologia       Date:  2015-09-26       Impact factor: 10.122

5.  Hypoadiponectinemia and its association with liver fibrosis in morbidly obese patients.

Authors:  Leyla Nazal; Arnoldo Riquelme; Nancy Solís; Margarita Pizarro; Alex Escalona; Mauricio Burotto; Juan Ignacio Méndez; Catalina Saint-Jean; María José Concha; Stefano Giovanni; Diego Awruch; Arturo Morales; Rene Baudrand; Gonzalo Carrasco; María Angélica Domínguez; Oslando Padilla; Manuel Espinoza; Juan Francisco Miquel; Flavio Nervi; Marco Arrese
Journal:  Obes Surg       Date:  2010-01-12       Impact factor: 4.129

6.  Pioglitazone, quercetin and hydroxy citric acid effect on hepatic biomarkers in Non Alcoholic Steatohepatitis.

Authors:  Krishna Mohan Surapaneni; Mallika Jainu
Journal:  Pharmacognosy Res       Date:  2014-04

Review 7.  Leptin's role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals.

Authors:  Hyun-Seuk Moon; Maria Dalamaga; Sang-Yong Kim; Stergios A Polyzos; Ole-Petter Hamnvik; Faidon Magkos; Jason Paruthi; Christos S Mantzoros
Journal:  Endocr Rev       Date:  2013-03-08       Impact factor: 19.871

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.